# INSPIRE: a Multi-Cancer Early Detection Study

> **NCT06440018** · — · RECRUITING · sponsor: **Singlera Genomics Inc.** · enrollment: 5350 (estimated)

## Conditions studied

- Lung Cancer
- Gastric Cancer
- Liver Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Breast Cancer
- Cervical Cancer
- Ovarian Cancer
- Endometrial Cancer
- Bladder Cancer
- Prostate Cancer
- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06440018
- **Lead sponsor:** Singlera Genomics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-20
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-02-28
- **Target enrollment:** 5350 (ESTIMATED)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06440018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06440018, "INSPIRE: a Multi-Cancer Early Detection Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06440018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*